PDL BioPharma, Inc. Receivables

Receivables of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Receivables growth rates and interactive chart. Accounts receivable (AR) is the balance of money due to a firm for goods or services delivered or used but not yet paid for by customers. Accounts receivables are listed on the balance sheet as a current asset. AR is any amount of money owed by customers for purchases made on credit. When a company makes a sale, it records revenues and a corresponding balance in accounts receivable. When an invoice is paid, the accounts payable account is reduced and cash is received. Receivables should grow in-line with revenue over time, if they are growing much faster, a company might be booking revenue too aggressively.


Highlights and Quick Summary

  • Receivables for the quarter ending June 29, 2020 was $6.15 Million (a -21.75% decrease compared to previous quarter)
  • Year-over-year quarterly Receivables decreased by -51.08%
  • Annual Receivables for 2019 was $13.6 Million (a -37.4% decrease from previous year)
  • Annual Receivables for 2018 was $21.6 Million (a -30.58% decrease from previous year)
  • Annual Receivables for 2017 was $31.2 Million (a -22.28% decrease from previous year)
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Receivables of PDL BioPharma, Inc.

Most recent Receivablesof PDLI including historical data for past 10 years.

Interactive Chart of Receivables of PDL BioPharma, Inc.

PDL BioPharma, Inc. Receivables for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $6.15 $7.87
2019 $6.56 $12.58 $17.87 $15.74 $13.55
2018 $21.65 $15.44 $19.53 $22.65 $21.65
2017 $31.18 $17.47 $20.8 $21.68 $31.18
2016 $40.12 $31.79 $98.24 $40.12
2015 $0.59 $0.4
2014 $0.3 $0.25 $1.35 $11.65 $0.3
2013 $0.3 $0.9 $0.15 $0.3
2012 $0.37 $0.37
2011 $0.6 $0.15 $0.6
2010 $0.47 $0.25 $0.15 $0.47

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.